www.vet-webinar.com uses cookies to offer you the best possible service. Read more

Webinars & e-learning courses All webinars

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats
Common Malignancies of the Skin - Mast Cell Tumors and Soft Tissue Sarcomas in Dogs and Cats

Tumors of the skin and subcutaneous tissues are the most common malignancies in dogs and cats accounting for over 30-40% of tumors in dogs and 29% in cats. Surgery is typically the first line treatment for most cutaneous and subcutaneous malignancies, and the phrase ‘a chance to cut is a chance to cure’ is certainly accurate with respect to many tumors.
Mast cell tumors and soft tissue sarcomas are the two most common skin malignancies in dogs whereas they are the third and fourth most common skin malignancies in cats (behind squamous cell carcinoma and basal cell tumors). This presentation will focus on mast cell tumors and soft tissue sarcomas in both species (squamous cell carcinomas and basal cell tumors will not be covered). The presentation will cover biologic behaviour of these tumors, considerations for staging and work-up, and treatment options with a focus on surgery, but discussion on adjuvant and alternative treatment methods will also be covered.

Recording from 30 June 2021

Speaker:

Dr-Stephanie-Colthurst-new.jpg

Stephanie Colthurst

DVM, Surgery BVSc. 

Stephanie is a small animal surgeon at Veterinary Specialist Services in Brisbane (Australia). She has worked in referral practice for 9 years. Following graduation from James Cook University in 2014, she completed a 12-month rotating internship at Veterinary Specialist Services followed by a second internship at Southpaws in Melbourne (Australia) in 2016 before enrolling into a surgical residency at Southpaws through the European College of Veterinary Surgeons (ECVS).

Stephanie successfully passed her memberships of the Australian and New Zealand College of Veterinary Scientists in Small Animal Surgery in 2018 and has just successfully passed her ECVS board examinations in February 2023 on her first attempt.

Stephanie returned to Veterinary Specialist Services in 2021. Whilst she enjoys all aspects of surgery, her particular interests are in soft tissue and oncologic surgery. She is passionate about keeping up to date with advances in veterinary research, so that she can strive to provide the best possible care for each patient and their owner.

Booking information

Duration: 0:51 h
Speaker: Stephanie Colthurst
from 1
54.90 US$
(inkl. tax)

You might also be interested in

tumor-grading-and-prognosis-in-veterinary-practice-1.jpeg
Sara Belluco
0:44 h

Tumor grading and prognosis in veterinary practice
Tumors are quite frequent in companion animals, with malignant forms representing 56% of all the tumors in dogs and 80% in cats. Predicting the survival time and treatment response for malignant tumors is necessary to evaluate the best care options for the animal. Histological tumor grading helps veterinarians to define the prognosis, but each tumor has its own grading system with different prognosis, in terms of survival rate, metastatic rate, recurrence incidence. It could be not so easy to get your bearings in the pathologic words of gradings. The goal of this seminar is to be able to correlate the validated prognosis to each tumor grading we will see. We will rapidly review what tumor grading is and how it is evaluated. Then we will spend some time to review some of the most important tumor gradings (mammary tumors, mast cell tumors, melanomas, soft tissue sarcomas) and the correlated and validated prognostic factors. At the end of the seminar you will be able to clearly understand your pathologist’s report based on the grading system, and to use it to give an appropriate prognosis to the owners.
Details
paraneoplastic-syndrome-1.jpeg
Valerie J. Poirier
0:45 h

Paraneoplastic Syndrome
Cancer can do anything..... Paraneoplastic syndrome are symptoms that occur at sites distant from a tumour or its metastasis. During this seminar, we will explore the categories of paraneoplastic syndromes and explain the mechanisms of those where it is elucidated. We will look at the comparative aspect of paraneoplastic syndrome in human medicine.
Details
staging-the-oncology-patient.png
Laura Brockley
0:57 h

Staging the Oncology Patient
Staging is one of the most important components of oncology case management. It involves determining the extent of local disease along with the presence or absence of regional or distant metastasis. The results of staging are used to give more accurate and informed treatment options along with prognostic information for each oncology patient. Some of the biggest challenges in staging is to consider how much staging is required for each case, which are the most appropriate tests, and if the results of these tests will impact treatment options and prognosis. I will discuss this information in a case-based and evidence-based approach, focusing on some of the more common cancers including canine mast cell tumours, lymphoma, oral tumours and apocrine gland anal sac adenocarcinomas.
Details
Back to overview
Webinars & e-learning courses